| http://www.w3.org/ns/prov#value | - The license agreement with Caliper supports our 'sample-to-answer' strategy and enables us to build upon IntegenX's core strengths in product development and integration, said Stevan Jovanovich, Ph.D., President and CEO of IntegenX. Microfluidics is a key enabling technology behind the high degree of automation and unprecedented analytical speed we have achieved.
|
